Secondaries announced 5.11.2016
IPOBoutique.Com rates secondary offerings to hit the tape with a ‘BUY’, ‘NEUTRAL’ or ‘AVOID’ rating. Senior Managing Partner Scott Sweet maintains a track record for all secondary’s he’s issued with a ‘BUY’ rating. Company: Loxo Oncology, Inc. Symbol: LOXO Price: Last trade $22.44 Description: Re-offer range $21.50-$22.00 Trade Date: 5/12 Shares: 1.3 million Underwriter(s) Citi,[…]